FDA approves J&J drug for advanced multiple myeloma
The FDA has approved an experimental drug from Johnson and Johnson that may be able to help advanced multiple myeloma. Multiple myeloma is cancer of the plasma cells in the blood – plasma cells are found in bone marrow. The drug is called Darzalex and is intended for patients who have already tried three other ...click here to read more